By Andrea Anderson

NEW YORK (GenomeWeb News) – In a paper appearing online yesterday in Nature Genetics, members of the Wellcome Trust Case Control Consortium 3 outlined their findings from the largest genome-wide association study of primary biliary cirrhosis to date — a study that yielded numerous new risk loci for the chronic liver condition.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.